FINWIRES · TerminalLIVE
FINWIRES

McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says

By

McKesson's (MCK) fiscal 2027 guidance is "encouraging," and its commentary on biosimilars should help ease recent pressure on drug distributors, Morgan Stanley said in a Friday note.

The investment firm said McKesson's targets and underlying assumptions support their bullish outlook on distributors that continue to benefit from structural tailwinds.

On Cencora (COR), the brokerage said the company faces idiosyncratic contract dynamics with Express Scripts that could lead to continued insourcing of biosimilar specialty drugs and add an overhang to the stock. The recent pullback in Cencora shares was overdone, according to the note.

Morgan Stanley raised their fiscal 2026 adjusted earnings estimate on Cencora to $17.76 from $17.63. Analysts surveyed by FactSet expect $17.73.

Morgan Stanley has an overweight rating and a $966 price target on McKesson.

The firm reiterated its overweight rating on Cencora and lowered its price target to $342 from $400.

Price: $265.08, Change: $+9.42, Percent Change: +3.68%

Related Articles

Wire

ESCO Technologies Fiscal Q2 Adjusted Earnings, Revenue Rise; Shares Fall After Hours

ESCO Technologies (ESE) reported fiscal Q2 adjusted earnings late Thursday of $1.91 per diluted share, up from $1.17 a year earlier.Three analysts polled by FactSet expected $1.84.Net sales in the three months ended March 31 rose to $309.3 million from $231.8 million a year earlier.Three analysts surveyed by FactSet expected $307.9 million.ESCO boosted full-year adjusted EPS guidance to $8 to $8.25 from its February forecast of $7.90 to $8.15. The company maintained its revenue outlook of $1.29 billion to $1.33 billion.Three analysts surveyed by FactSet project EPS of $8.15 on revenue of $1.32 billion.The company kept its quarterly dividend at $0.08 per share, payable July 17 to stockholders of record July 2.ESCO shares fell 6.1% in after-hours trading.

$ESE
Wire

Gen Digital Fiscal Q4 Adjusted Earnings, Revenue Rise; Shares Gain After Hours

Gen Digital (GEN) reported fiscal Q4 adjusted earnings late Thursday of $0.67 per diluted share, up from $0.59 a year earlier.Analysts polled by FactSet expected $0.65.Revenue in the three months ended April 3 rose to $1.28 billion from $1.01 billion a year earlier.Analysts surveyed by FactSet expected $1.25 billion.Gen Digital expects Q1 EPS of $0.68 to $0.70 on revenue of $1.30 billion to $1.325 billion.Analysts polled by FactSet project EPS of $0.68 on revenue of $1.27 billion.The company expects fiscal 2027 EPS of $2.85 to $2.95 on revenue of $5.33 billion to $5.43 billion.Analysts surveyed by FactSet project EPS of $2.85 on revenue of $5.24 billion.Gen Digital shares jumped 9% in after-hours trading.

$GEN
Wire

JFrog Q1 Non-GAAP Earnings, Revenue Rise; Lifts 2026 Guidance

JFrog (FROG) reported Q1 non-GAAP earnings late Thursday of $0.27 per diluted share, up from $0.20 a year earlier.Analysts polled by FactSet expected $0.21.Revenue for the quarter ended March 31 was $154.0 million, up from $122.4 million a year earlier.Analysts surveyed by FactSet expected $147.4 million.For Q2, the company expects non-GAAP EPS of $0.23 to $0.25 on revenue of $154 million to $156 million. Analysts expect $0.21 and $151.7 million, respectively.For 2026, JFrog now expects non-GAAP EPS of $0.93 to $0.97 on revenue of $628 million to $632 million, up from the prior forecast of non-GAAP EPS of $0.88 to $0.92 on revenue of $623 million to $628 million.Analysts expect $0.90 and $627.7 million, respectively.Shares of JFrog rose 15% in after-hours activity.

$FROG